Analyze Diet
Revue scientifique et technique (International Office of Epizootics)1986; 5(4); 837-867; doi: 10.20506/rst.5.4.273

Equine viral rhinopneumonitis.

Abstract: No abstract available
Publication Date: 1986-12-01 PubMed ID: 32731653DOI: 10.20506/rst.5.4.273Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Cite This Article

APA
Bryans JT, Allen GP. (1986). Equine viral rhinopneumonitis. Rev Sci Tech, 5(4), 837-867. https://doi.org/10.20506/rst.5.4.273

Publication

ISSN: 0253-1933
NlmUniqueID: 8712301
Country: France
Language: fre
Volume: 5
Issue: 4
Pages: 837-867

Researcher Affiliations

Bryans, J T
    Allen, G P

      Citations

      This article has been cited 5 times.
      1. Kim SK, Shakya AK, O'Callaghan DJ. Interferon Gamma Inhibits Equine Herpesvirus 1 Replication in a Cell Line-Dependent Manner. Pathogens 2021 Apr 16;10(4).
        doi: 10.3390/pathogens10040484pubmed: 33923733google scholar: lookup
      2. Oladunni FS, Horohov DW, Chambers TM. EHV-1: A Constant Threat to the Horse Industry. Front Microbiol 2019;10:2668.
        doi: 10.3389/fmicb.2019.02668pubmed: 31849857google scholar: lookup
      3. Kim SK, Shakya AK, O'Callaghan DJ. Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response. Antiviral Res 2019 Sep;169:104546.
      4. Kim SK, Shakya AK, O'Callaghan DJ. Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge. J Virol 2016 Sep 15;90(18):8090-104.
        doi: 10.1128/JVI.00986-16pubmed: 27356904google scholar: lookup
      5. Smith PM, Zhang Y, Jennings SR, O'Callaghan DJ. Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice. J Virol 1998 Jul;72(7):5366-72.